Viral expression cassette elements to enhance transgene target specificity and expression in gene therapy.
- 1 January 2015
- journal article
- review article
- Vol. 19 (102) , 49-57
Abstract
Over the last five years, the number of clinical trials involving AAV (adeno-associated virus) and lentiviral vectors continue to increase by about 150 trials each year. For continued success, AAV and lentiviral expression cassettes need to be designed to meet each disease's specific needs. This review discusses how viral vector expression cassettes can be engineered with elements to enhance target specificity and increase transgene expression. The key differences relating to target specificity between ubiquitous and tissue-specific promoters are discussed, as well as how endogenous miRNAs and their target sequences have been used to restrict transgene expression. Specifically, relevant studies indicating how cis-acting elements such as introns, WPRE, polyadenylation signals, and the CMV enhancer are highlighted to show their utility for enhancing transgene expression in gene therapy applications. All discussion bears in mind that expression cassettes have space constraints. In conclusion, this review can serve as a menu of vector genome design elements and their cost in terms of space to thoughtfully engineer viral vectors for gene therapy.Keywords
This publication has 80 references indexed in Scilit:
- Immunodominant Liver-Specific Expression Suppresses Transgene-Directed Immune Responses in Murine Pompe DiseaseHuman Gene Therapy, 2012
- Optimizing Promoters for Recombinant Adeno-Associated Virus-Mediated Gene Expression in the Peripheral and Central Nervous System Using Self-Complementary VectorsHuman Gene Therapy, 2011
- MicroRNA therapeuticsGene Therapy, 2011
- Intravitreal Injection of AAV2 Transduces Macaque Inner RetinaInvestigative Ophthalmology & Visual Science, 2011
- Optimal promoter usage for lentiviral vector-mediated transduction of cultured central nervous system cellsJournal of Neuroscience Methods, 2010
- Desmin-regulated Lentiviral Vectors for Skeletal Muscle Gene TransferMolecular Therapy, 2010
- Recent Advances in Lentiviral Vector Development and ApplicationsMolecular Therapy, 2010
- Lentiviral vectors containing an enhancer-less ubiquitously acting chromatin opening element (UCOE) provide highly reproducible and stable transgene expression in hematopoietic cellsBlood, 2007
- Improving Transcriptional Termination of Self-inactivating Gamma-retroviral and Lentiviral VectorsMolecular Therapy, 2007
- CMV enhancer/human PDGF-β promoter for neuron-specific transgene expressionGene Therapy, 2003